ScrutarSign up free

HENRY SCHEIN INC (HSIC)

SEC filings, insider trading & institutional ownership from EDGAR.

NasdaqHealth CareHealth Care Equipment & Supplies

Henry Schein, Inc., headquartered in Melville, New York, is a health care solutions company and, by its own assessment, the world's largest provider of health care products and services to office-based dental and medical practitioners and alternate sites of care. With 94 years of industry experience, the company serves more than one million customers worldwide, including dental practices, laboratories, physician practices, ambulatory surgery centers, and various institutional and home health care providers. The company employs over 25,000 people globally (approximately 48% in the U.S. and 52% internationally) and operates in 34 countries and territories, having grown through both organic expansion and strategic acquisitions.

Henry Schein stocks more than 300,000 branded and corporate-brand products, supported by an infrastructure of over 5.4 million square feet across 38 distribution centers and 0.6 million square feet across 17 manufacturing facilities worldwide, enabling efficient order fulfillment and positioning the company as a single-source supplier for its customers. The business operates through three reportable segments: Global Distribution and Value-Added Services, which distributes national and corporate-brand dental and medical merchandise, equipment, and technical services, along with value-added offerings such as financial services, continuing education, and practice consulting; Global Specialty Products, encompassing the manufacturing, marketing, and sale of dental implants, biomaterials, endodontic, orthodontic, and orthopedic products; and Global Technology, which develops and distributes practice management software and e-services for health care providers. The industry in which Henry Schein operates is fragmented, ranging from small independent practices to large dental support organizations and integrated delivery networks, and is characterized by frequent small-quantity orders requiring rapid, reliable fulfillment.

The company faces significant competition across its segments: in North American dental distribution, primary competitors include Patterson Dental and Benco Dental Supply Company; in U.S. medical distribution, main rivals are McKesson Corporation and Medline Industries; outside the U.S., competitors are largely regional and local dental distributors including Cadence Group, Proclinic Group, and Planmeca Group, among others. In Global Specialty Products, key competitors include Straumann, Envista, Zimvie, and Dentsply Sirona for implants, and Geistlich Pharma and Botiss Biomaterials in biomaterials. In Global Technology, competitors include Patterson's Eaglesoft, Carestream Dental, Open Dental Software, and Epic Systems, among others.

The company manufactures specialty products such as dental implants, endodontics, and orthopedics at its 17 manufacturing sites, while also outsourcing certain production, and sources raw materials from distributors and mills, maintaining what it believes is a readily available supply chain despite occasional reliance on single or limited suppliers.

AI-summarized from Item 1 (Business) of the company's most recent 10-K filing.

RevenueFY2025
$13.18B
▲ 4.0%YoY
Net incomeFY2025
$419.00M
▲ 5.3%YoY
Diluted EPSFY2025
$3.27
▲ 7.2%YoY
Gross margin
31.1%
▼ 55 bpsYoY
Insider net6 mo
+4.1K
shares1 sells1 buys
Institutions
39
$4.97B held

Financials

As reported to the SEC via XBRL, no adjustments

All financials →
Revenue & net income
$5B$10B$15B
FY2022FY2023FY2024FY2025
RevenueNet income
FY2025 highlightsfrom 10-K
Gross profit$4.11B
Operating income$653.00M
Diluted EPS$3.27
Gross margin31.1%
Net margin3.2%

Latest filings

10-K, 10-Q, 8-K, Form 4 & 13D/G. Sourced directly from SEC EDGAR

All filings →
FormFiledAccession
4Albertini AndreaSep 9, 2026EDGAR
SC 13GFMR LLC and 1 other reporting personAug 6, 2026EDGAR
10-QAug 4, 2026EDGAR
8-KAug 4, 2026EDGAR
8-KJul 30, 2026EDGAR
4DANIEL WILLIAM KJun 15, 2026EDGAR
4/ABERGMAN STANLEY MMay 26, 2026EDGAR
4BERGMAN STANLEY MMay 22, 2026EDGAR

Insider trading

From Form 4 filings

All →
InsiderDateType
Albertini AndreaSep 8, 2026Disposition
Albertini AndreaSep 8, 2026Tax withholding
DANIEL WILLIAM KJun 12, 2026Grant / award
BERGMAN STANLEY MMay 26, 2026Gift
BERGMAN STANLEY MMay 21, 2026Gift

Top holders

13F & 13D/G · latest quarter

All →
HolderStakeFiledValue
FMR LLC6.7%Aug 13, 2026$630.90M
BlackRock, Inc.6.2%Aug 7, 2026$586.70M
Vanguard Capital Management5.6%Aug 13, 2026$530.07M
JPMORGAN CHASE & CO3.8%Aug 12, 2026$366.43M
STATE STREET CORPORATION3.8%Aug 7, 2026$359.58M

HSIC's filings are public. The insight is one click away.

Scrutar's AI reads every HSIC filing and surfaces what matters. Red flags, risk shifts, disclosure quality and key relationships. Cited to the source, free with an account.

Analyze HSIC filingsNo credit cardAI reports included on the free plan

Never miss a HSIC filing.

Get an email when HSIC files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.

Free foreverNo account requiredOne-click unsubscribe

Protected by reCAPTCHA. Privacy & Terms

Data as of Sep 16, 2026Source: SEC EDGAR.